Evidence map›Paper›PMID 39912859›Full record

ArticleEuropean journal of epidemiology2025

Use of mortality tables by level of deprivation in the study of social inequalities in cancer survival.

Sarah Wilson, Ophelie Merville, Olivier Dejardin, Josephine Gardy, Quentin Rollet, Valerie Jooste, Francim Network, Florence Molinie, Laure Tron, Guy Launoy

Abstract read
In one paragraph

Article in European journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarah WilsonUniversité de Caen Normandie, ANTICIPE U1086 INSERM, 14000, University of Caen Normandy Centre Hospitalier Universitaire de Caen Bâtiment Biologie, Recherche Avenue de la Côte de Nacre CS 30001, 14033, Caen Cedex 9, France. sarah.wilson@unicaen.fr.ORCID http://orcid.org/0000-0002-5579-6996
Ophelie MervilleINSERM UMR1295, Équipe EQUITY, CERPOP, Université Toulouse III, Toulouse, France.
Olivier DejardinUniversité de Caen Normandie, ANTICIPE U1086 INSERM, 14000, University of Caen Normandy Centre Hospitalier Universitaire de Caen Bâtiment Biologie, Recherche Avenue de la Côte de Nacre CS 30001, 14033, Caen Cedex 9, France.
Josephine GardyUniversité de Caen Normandie, ANTICIPE U1086 INSERM, 14000, University of Caen Normandy Centre Hospitalier Universitaire de Caen Bâtiment Biologie, Recherche Avenue de la Côte de Nacre CS 30001, 14033, Caen Cedex 9, France.
Quentin RolletUniversité de Caen Normandie, ANTICIPE U1086 INSERM, 14000, University of Caen Normandy Centre Hospitalier Universitaire de Caen Bâtiment Biologie, Recherche Avenue de la Côte de Nacre CS 30001, 14033, Caen Cedex 9, France.
Valerie JoosteRegistre Bourguignon Des Cancers Digestifs, Dijon University Hospital, INSERM UMR 1231, UFR Santé de Bourgogne, Dijon, France.
Francim NetworkFRANCIM Network, Toulouse, France.
Florence MolinieFRANCIM Network, Toulouse, France.
Laure TronUniversity Clinic of Hepato-Gastroenterology, Grenoble Alpes University Hospital, Grenoble, France.
Guy LaunoyUniversité de Caen Normandie, ANTICIPE U1086 INSERM, 14000, University of Caen Normandy Centre Hospitalier Universitaire de Caen Bâtiment Biologie, Recherche Avenue de la Côte de Nacre CS 30001, 14033, Caen Cedex 9, France.

Funding

Ligue Contre le Cancer Equipe Labellisée LIGUE 2022
6 · The paper itself

Abstract

backgroundPrevious studies have reported lower net survival probabilities for socioeconomically deprived patients, using non-deprivation specific lifetables. Not accounting for the social gradient in background mortality could potentially overestimate the effect of deprivation on net survival. The aim of this study was to estimate the impact of taking into account the social gradient of expected mortality in the general population on the study of the social gradient of survival of people with cancer.

methodsFrench cancer registry data was analyzed, with 190,902 incident cases of nineteen cancer sites between 2013 and 2015. Deprivation was measured using the European deprivation index (EDI). Net survival was estimated thanks to additive models with French lifetables stratified on deprivation level with the EDI, using the non-parametric Pohar-perme method and flexible excess hazard modelling with multidimensional penalized splines, firstly with non-specific lifetables then with the deprivation specific-lifetables.

resultsA significant effect of EDI on excess mortality hazard (EMH) remained when using the deprivation-specific lifetables for colorectal, lung cancer and melanoma in both sexes, and esophagus, bladder, head and neck and liver cancer for men, and breast, cervix and uterine cancer for women. The only site where the effect of EDI on EMH was no longer significant when using deprivation-specific lifetables was prostate cancer.

conclusionsThe use of deprivation-specific lifetables confirms the existence of a social gradient in cancer survival, indicating that these inequalities do not result from inequalities in background mortality. Development of such deprivation-specific lifetables for future years is crucial to understand mechanisms of social inequalities and work towards reducing the social burden.

Indexed as

Health Status DisparitiesLife TablesNeoplasmsSocial DeprivationAdultAgedFemaleFranceHumansMaleMiddle AgedRegistriesSocioeconomic FactorsCancerMortality tablesNet survivalSocial deprivation

Identifiers

PMID39912859
PMCPMC12018625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.